Beverly Folmer

Beverly Folmer has extensive experience in regulatory affairs and pharmaceutical development, currently serving as the Director of Global Regulatory Affairs CMC at Incyte since January 2003. In this role, Beverly manages regulatory submissions and strategy for investigational and marketed products, ensuring compliance with regulatory guidance and internal policies. Previous positions at Incyte include Associate Director and Senior Manager, focusing on CMC submissions for small and large molecules. Prior to Incyte, Beverly held various roles at DuPont Pharmaceuticals, Elan, and Ruetgers-Nease Corporation, contributing to research and development projects in medicinal chemistry and process optimization. Beverly's educational background includes a Master’s Degree in QA/RA Drug Development from Temple University School of Pharmacy and a B.S. in Chemistry from PennWest Clarion.